Evidence on Nirsevimab- and Clesrovimab immunization to prevent RSV- associated respiratory tract infections in preterm born children younger than 24 months: a scoping review protocol
Authors
Kari Risnes (ORCID: https://orcid.org/0000-0001-6599-0146)
Evidence on Nirsevimab- and Clesrovimab immunization to prevent RSV- associated respiratory tract infections in preterm born children younger than 24 months: a scoping review protocol
Kari Risnes, Mette Engan
Journal
Zenodo (CERN European Organization for Nuclear Research)
Topics
Respiratory viral infections research
article
Evidence on Nirsevimab- and Clesrovimab immunization to prevent RSV- associated respiratory tract infections in preterm born children younger than 24 months: a scoping review protocol
Kari Risnes, Mette Engan
article en
Abstract
No abstract available for this paper.
Publication Tag
Zenodo (CERN European Organization for Nuclear Research)
Institutions
Norwegian University of Science and Technology (NO), Haukeland University Hospital (NO)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Evidence on Nirsevimab- and Clesrovimab immunization to prevent RSV- associated respiratory tract infections in preterm born children younger than 24 months: a scoping review protocol — Kari Risnes, Mette Engan · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS